At the dawn of personalized reproductive medicine: opportunities and challenges with incorporating multigene panel testing into fertility care.
作者信息
Yurttas Beim Piraye, Parfitt David-Emlyn, Tan Lei, Sugarman Elaine A, Hu-Seliger Tina, Clementi Caterina, Levy Brynn
机构信息
Celmatix Inc., New York, NY, USA.
Department of Pathology & Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
出版信息
J Assist Reprod Genet. 2017 Dec;34(12):1573-1576. doi: 10.1007/s10815-017-1068-2. Epub 2017 Oct 23.
Abstract
摘要
相似文献
1
At the dawn of personalized reproductive medicine: opportunities and challenges with incorporating multigene panel testing into fertility care.个性化生殖医学的曙光：将多基因检测纳入生育治疗的机遇与挑战
J Assist Reprod Genet. 2017 Dec;34(12):1573-1576. doi: 10.1007/s10815-017-1068-2. Epub 2017 Oct 23.
2
Personalized precision reproductive medicine and diagnostics.个性化精准生殖医学与诊断
Syst Biol Reprod Med. 2017 Feb;63(1):1. doi: 10.1080/19396368.2017.1278984.
3
Why the way we look at things in reproductive medicine is changing.生殖医学领域中我们看待事物的方式为何正在发生变化。
J Assist Reprod Genet. 2017 Nov;34(11):1403-1404. doi: 10.1007/s10815-017-1077-1.
4
Reproductive medicine 2013: the year in review.生殖医学2013回顾
J Assist Reprod Genet. 2013 Dec;30(12):1527-9. doi: 10.1007/s10815-013-0142-7.
5
The dynamic nature of reproductive endocrinology and infertility.
Obstet Gynecol Clin North Am. 2015 Mar;42(1):xiii-xiv. doi: 10.1016/j.ogc.2014.11.002. Epub 2014 Dec 13.
6
Proceedings of the New York University School of Medicine Reproductive Ethics Conference: Challenges and Solutions.纽约大学医学院生殖伦理会议论文集：挑战与解决方案
J Assist Reprod Genet. 2019 Sep;36(9):1767-1769. doi: 10.1007/s10815-019-01522-w. Epub 2019 Jul 25.
7
Personalized reproductive medicine: regulatory considerations.个性化生殖医学：监管考虑因素。
Fertil Steril. 2018 Jun;109(6):964-967. doi: 10.1016/j.fertnstert.2018.03.027.
8
The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg.癌症患者生育力保存面临的挑战：专访迈克尔·格里恩伯格。
Future Oncol. 2018 Mar;14(6):497-498. doi: 10.2217/fon-2017-0673. Epub 2018 Feb 9.
9
Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary.生殖健康与生育的环境挑战峰会会议纪要：执行摘要
Fertil Steril. 2008 Feb;89(2 Suppl):e1-e20. doi: 10.1016/j.fertnstert.2008.01.065.
10
Personalized reproductive medicine on the brink: progress, opportunities and challenges ahead.个体化生殖医学的前沿：进展、机遇与挑战。
Reprod Biomed Online. 2013 Dec;27(6):611-23. doi: 10.1016/j.rbmo.2013.09.010.
引用本文的文献
1
Prenatal Imaging: Egg Freezing, Embryo Selection and the Visual Politics of Reproductive Time.产前影像：卵子冷冻、胚胎选择与生殖时间的视觉政治
Catalyst (San Diego). 2018 Oct 16;4(2):1-35. doi: 10.28968/cftt.v4i2.29908.
2
Data-Driven Medicine in the Diagnosis and Treatment of Infertility.数据驱动医学在不孕症诊断与治疗中的应用
J Clin Med. 2022 Oct 29;11(21):6426. doi: 10.3390/jcm11216426.
3
Genetic incompatibility of the reproductive partners: an evolutionary perspective on infertility.生殖伴侣间的遗传不相容性：不孕不育的进化视角。
Hum Reprod. 2021 Nov 18;36(12):3028-3035. doi: 10.1093/humrep/deab221.
4
Nanotechnology in reproductive medicine: Opportunities for clinical translation.生殖医学中的纳米技术：临床转化机遇
Clin Exp Reprod Med. 2020 Dec;47(4):245-262. doi: 10.5653/cerm.2020.03650. Epub 2020 Nov 16.
5
Precise Personalized Medicine in Gynecology Cancer and Infertility.妇科癌症与不孕症中的精准个性化医疗
Front Cell Dev Biol. 2020 Jan 17;7:382. doi: 10.3389/fcell.2019.00382. eCollection 2019.
6
Personalized medicine: motivation, challenges, and progress.个性化医学：动机、挑战与进展。
Fertil Steril. 2018 Jun;109(6):952-963. doi: 10.1016/j.fertnstert.2018.05.006.
本文引用的文献
1
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource.评估基因与疾病关联的临床有效性：临床基因组资源开发的循证框架
Am J Hum Genet. 2017 Jun 1;100(6):895-906. doi: 10.1016/j.ajhg.2017.04.015. Epub 2017 May 25.
2
Precision reproductive medicine: multigene panel testing for infertility risk assessment.精准生殖医学：用于不孕风险评估的多基因检测板检测
J Assist Reprod Genet. 2017 Aug;34(8):967-973. doi: 10.1007/s10815-017-0938-y. Epub 2017 May 3.
3
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.高通量基因组学与难治疗的晚期癌症的临床结局：MOSCATO 01 试验结果。
Cancer Discov. 2017 Jun;7(6):586-595. doi: 10.1158/2159-8290.CD-16-1396. Epub 2017 Apr 1.
4
Inflammation and Human Ovarian Follicular Dynamics.炎症与人类卵巢卵泡动力学
Semin Reprod Med. 2015 Jul;33(4):270-5. doi: 10.1055/s-0035-1554928. Epub 2015 Jul 1.
5
A national survey on public perceptions of miscarriage.一项关于公众对流产看法的全国性调查。
Obstet Gynecol. 2015 Jun;125(6):1313-1320. doi: 10.1097/AOG.0000000000000859.
6
Single nucleotide polymorphisms in premature ovarian failure-associated genes in a Chinese Hui population.中国回族人群中卵巢早衰相关基因的单核苷酸多态性
Mol Med Rep. 2015 Aug;12(2):2529-38. doi: 10.3892/mmr.2015.3762. Epub 2015 May 8.
7
PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update.PI3K/PTEN/Akt和TSC/mTOR信号通路、卵巢功能障碍与不孕症：最新进展
J Mol Endocrinol. 2014 Dec;53(3):R103-18. doi: 10.1530/JME-14-0220. Epub 2014 Oct 13.
8
Mutant ZP1 in familial infertility.家族性不育症中的突变 ZP1。
N Engl J Med. 2014 Mar 27;370(13):1220-6. doi: 10.1056/NEJMoa1308851.
9
Evaluation and treatment of recurrent pregnancy loss: a committee opinion.复发性妊娠丢失的评估与治疗：委员会意见。
Fertil Steril. 2012 Nov;98(5):1103-11. doi: 10.1016/j.fertnstert.2012.06.048. Epub 2012 Jul 24.
10
Risk factor changes for sudden infant death syndrome after initiation of Back-to-Sleep campaign.“安睡反侧”运动实施后婴儿猝死综合征风险因素的变化。
Pediatrics. 2012 Apr;129(4):630-8. doi: 10.1542/peds.2011-1419. Epub 2012 Mar 26.
Zotero 插件